Skip to content

Eagle Capital Select Equity EAGL Decrease In Accrual Of Issuance Costs From Warrant Exchange

Decrease In Accrual Of Issuance Costs From Warrant Exchange at other companies

NextNav logo
NextNavNN
-$2.25M
NovaGold Resources logo
NovaGold ResourcesNG
$0-100%
Evommune
 logo
Evommune EVMN
$150
NextNav logo
NextNavNN
-$2.25M
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$409.25K
Evommune
 logo
Evommune EVMN
$150

Other financials

Income statement

See full
Revenue$72.8M+4.1%
Gross profit$6.9M-61.7%
Operating income-$14.3M-1,231%
Net income-$12.9M-100.0%
EPS (diluted)-$0.13-85.7%

Balance sheet

See full
Cash & equivalents$5.5M-84.2%
Total debt$11.0M-20.4%
Total equity$376.9M-9.2%
Total assets$539.5M-4.1%

Cash flow

See full
Operating cash flow$7.0M+78.7%
CapEx$176.0K-71.4%
Free cash flow$6.9M+106%

Valuation

See full
Market cap$0+42.2%

Profitability

See full
Gross margin9.8%-32.3pp
Operating margin-14.8%-36.9pp
Net margin-13.5%-26.2pp
FCF margin23.8%-6.0pp

Returns & leverage

See full
Return on equity-11%-22.2pp
Debt / equity0.0×
Current ratio0.8×-1.1×

Where this comes from

Reported directly by Eagle Capital Select Equity in its filing.

Tagged under the XBRL concept th:DecreaseInAccrualOfIssuanceCostsFromWarrantExchange.

The official record: Eagle Capital Select Equity’s 10-K, filed March 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eagle Capital Select Equity's decrease in accrual of issuance costs from warrant exchange.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eagle Capital Select Equity's decrease in accrual of issuance costs from warrant exchange?
Eagle Capital Select Equity (EAGL) reported decrease in accrual of issuance costs from warrant exchange of $376K in Q4 2023.
What does decrease in accrual of issuance costs from warrant exchange mean?
Represents the reduction in accrued liabilities associated with the costs of issuing warrants or similar equity-linked instruments. This reflects the settlement or adjustment of expenses related to capital raising activities. It provides insight into the non-cash impact of financing arrangements on the company's balance sheet.